San Francisco Bay Area biotech stories.
Thursday, August 9, 2012
Growing Nodality strikes drug-development deal with Pfizer
Nodality Inc. scored a deal Thursday to help
, the world's largest drug maker, better develop drugs
. The multi-year deal, financial terms for which weren't disclosed, initially will focus on autoimmune diseases, particularly lupus. Plus, Pfizer has an option to use Nodality's technology to develop companion diagnostics.
Share to Twitter
Share to Facebook
Share to Pinterest
Kleiner Perkins Caufield Byers
Pfizer Venture Investments
Post a Comment
Post Comments (Atom)